Quantitation of microbicidal activity of mononuclear phagocytes: an in vitro technique.

• Main Authors: Rege N, Dahanukar S
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 1993-01-01
• Series: Journal of Postgraduate Medicine
• Subjects: Adult; Animal; Candida; physiology; Human; Macrophages; Peritoneal; drug effects; Metronidazole; pharmacology; Monocytes; Phagocytosis; Plant Extracts; Rats; Sprague-Dawley
• Online Access: http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1993;volume=39;issue=1;spage=22;epage=5;aulast=Rege
• ISSN: 0022-3859; 0972-2823

An in vitro assay technique was set up to determine the phagocytic and microbicidal activity of a monocyte-macrophage cell line using Candida species as test organisms. The norms were determined for the activity of peritoneal macrophages of rats (24.69 +/- 2.6% phagocytosis and 35.4 +/- 5.22% ICK) and human (27.89 +/- 3.63% phagocytosis and 50.91 +/- 6.3% ICK). The assay technique was used to test the degree of activation of macrophages induced by metronidazole, Tinospora cordifolia and Asparaqus racemousus and to compare their effects with a standard immunomodulator muramyl-dipeptide. All the three test agents increased the phagocytic and killing capacity of macrophages in a dose dependent manner upto a certain dose, beyond which either these activities were found to have plateaued or decreased. The optimal doses for MDP, Metronidazole, Asparagus racemosus and Tinospora cordifolia were found to be 100 micrograms, 300 mg/kg, 200 mg/kg and 100 mg/kg respectively. Patients with cirrhosis were screened for defects in monocyte function. The depressed monocyte function (20.58 +/- 5% phago and 41.24 +/- 12.19% ICK; P < 0.05) was observed indicating a compromised host defense. The utility of this candidicidal assay in experimental and clinical studies is discussed.